Advent France Biotechnology
Overview
Advent France Biotechnology is a venture capital firm that invests in a range of sectors within the life sciences - specifically in therapeutics-oriented projects. AFB's unique strategy combines early-stage investments in promising enterprises and strong entrepreneurial support to strengthen the company's growth. As an early-stage investor, they act as a catalyst to create companies based on innovations coming from academic research. They have established relationships with leading research institutions and technology transfer offices in Europe and benefit from the support of a strong network of scientific, clinical, industry and financial partners.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| ARTHEx Biotech | Sep 2025 | Series B | Co-investor |
| IntegraTherapeutics | Sep 2025 | VC Round | Co-investor |
| Augustine Therapeutics | Mar 2025 | Series A | Co-investor |
| Astraveus | Jun 2023 | Seed | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Advent France Biotechnology based?
Advent France Biotechnology is headquartered in Paris, Île-de-France, France.
When was Advent France Biotechnology founded?
Advent France Biotechnology was founded in 2015.
How many portfolio companies does Advent France Biotechnology have?
Advent France Biotechnology has 10 portfolio companies in Caplight's dataset.
What are some companies in Advent France Biotechnology's portfolio?
Recent investments visible on Caplight include ARTHEx Biotech, IntegraTherapeutics, Augustine Therapeutics, Augustine Therapeutics, Astraveus.
What was Advent France Biotechnology's most recent investment?
Advent France Biotechnology's most recent investment on Caplight was in ARTHEx Biotech in 2025.
What sectors does Advent France Biotechnology focus on?
Advent France Biotechnology focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Advent France Biotechnology focus on?
Advent France Biotechnology typically invests at the Early stage.
What is Advent France Biotechnology's AUM?
Advent France Biotechnology's assets under management are estimated between $100.0M and $250.0M.